Calls grow for U.S. to help India with spare COVID-19 vaccines
The Hindu
Politicians, doctors have pressed for a temporary waiver of intellectual property rights governing the production of vaccines and therapeutics
As a second wave of the COVID-19 pandemic rages in India, calls are growing in the United States to send spare vaccine doses to New Delhi. This is on top of calls of stakeholder requests to facilitate the export of vaccine raw materials and to support a temporary waiver of intellectual property rights governing the production of vaccines and therapeutics. “India is reporting the world’s highest ever single-day COVID case rise. Earth Day is about the health of the planet and everyone and everything on it. The U.S. has more than enough vaccine for every American, but we are denying countries like India desperately needed support,” US Senator Ed Markey from Massachusetts tweeted on Thursday. “India is in the throes of a horrendous COVID surge … They are struggling to get more people vaccinated. We [the U.S.] are sitting on 35-40 million doses of Astra Zeneca vaccine Americans will never use,” Ashish K. Jha, a doctor and Dean of the Brown University School of Public Health tweeted.More Related News